glp 1 and sglt2 GLP-1 Receptor Agonists SGLT2 Inhibitors and GLP-1 Receptor

One consequence of this popularity is that despite their high cost, the GLP-1 agonist medications have seen demand outstrip their supply resulting in shortages making their availability to treat diabetes more limited

GLP-1RAs have been proven to reduce the risk of major adverse cardiovascular events (MACE) occurrence, including death from cardiovascular causes, non-fatal myocardial infarction and non-fatal stroke, as well as all-cause mortality in T2DM and patients with obesity ( The glucocorticoid receptors are present in GLP-1-producing cells, and their activation diminishes the secretory responsiveness of these cells ( 4.1 Efficacy of GLP-1 receptor agonist therapy in SID Considering their beneficial effects on body weight, effective glycemic control, and low risk of hypoglycaemia, GLP-1 RAs may be suitable therapeutic options for SID and SIH, either as adjunctive therapy or as primary treatment

Yes and no

Berberine may interact with diabetes medications, particularly increasing hypoglycaemia risk when combined with insulin or sulfonylureas, and may affect the metabolism of other medicines through enzyme inhibition

Drinking alcohol excessively: Alcohol consumption can lower blood sugar levels, which may interfere with how GLP-1 works in the body

Sobobas website currently highlights GLP-1 options, including Mounjaro, tirzepatide , Semaglutide , and Ozempic , along with Orange County clinic locations and contact information